Global Focal Segmental Glomerulosclerosis Market to Reach $20.1 Billion by 2030
The global market for Focal Segmental Glomerulosclerosis estimated at US$12.8 Billion in the year 2023, is expected to reach US$20.1 Billion by 2030, growing at a CAGR of 6.6% over the period 2023-2030. Primary Disease, one of the segments analyzed in the report, is expected to record 6.7% CAGR and reach US$16.2 Billion by the end of the analysis period. Growth in the Secondary Disease segment is estimated at 6.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 6.1% CAGR
The Focal Segmental Glomerulosclerosis market in the U.S. is estimated at US$3.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook